BenjaminAlexanderNacevMDPhD

Oncology • New York, NY

Sarcoma

Assistant Attending

Join to view full profile

Dr. Nacev is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nacev's full profile

Already have an account?

Office
300 East 66th Street
New York, NY 10065
Phone+1 646-888-6853

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Johns Hopkins UniversityResidency, Internal Medicine, 2013 - 2016
Johns Hopkins University School of MedicineClass of 2013, MD, PhD

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2018 - 2024
PA State Medical License 2022 - 2024
NJ State Medical License 2021 - 2023
NC State Medical License 2020 - 2022
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

52 citations
Oncohistone mutations enhance chromatin remodeling and alter cell fates.
John D. Bagert, Michelle M. Mitchener, Agata L Patriotis, Barbara E. Dul, Felix Wojcik
Nature Chemical Biology. 2021-03-01
121 citations
The epigenomics of sarcoma.
Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, Jamie S.E. Yu, C. David Allis
Nature Reviews. Cancer. 2020-08-11
8 citations
A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma.
Christina V. Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum
Clinical Cancer Research. 2021-10-19

Lectures

Oncohistones and Applications in Cancer Care
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

Damon Runyon Cancer Research Foundation Awards $3.6 Million to Top Clinical InvestigatorsJuly 21st, 2023